Toggle navigation
Otsi
Publikatsioonid
Profiilid
Registrid
Abi ja info
Switch to English
Intranet
Publikatsioonid
Profiilid
Registrid
Abi ja info
English
Intranet
Andmebaasid
Publikatsioonid
Otsing
Valitud kirjed
0
Parkinson disease (võtmesõna)
Kõikidelt väljadelt
Autori otsing
Märksõna otsing
Pealkirja otsing
algab
sisaldab
täpne vaste
Kõikidelt väljadelt
Autori otsing
Märksõna otsing
Pealkirja otsing
algab
sisaldab
täpne vaste
—
Kõikidelt väljadelt
Autori otsing
Märksõna otsing
Pealkirja otsing
algab
sisaldab
täpne vaste
—
Kõikidelt väljadelt
Autori otsing
Märksõna otsing
Pealkirja otsing
algab
sisaldab
täpne vaste
—
Kõikidelt väljadelt
Autori otsing
Märksõna otsing
Pealkirja otsing
algab
sisaldab
täpne vaste
—
Lisa tingimus
Liitotsing
Tühista
teaviku laadid
raamat
artikkel ajakirjas
artikkel ajalehes
artikkel kogumikus
dissertatsioon
Open Access
Teaduspublikatsioon
aasta
Kirjeid leitud
2
Vaata veel..
(3/97)
Ekspordi
ekspordi kõik päringu tulemused
(2)
Salvesta TXT fail
Salvesta PDF fail
prindi
Märgitud kirjetega toimetamiseks ava
valitud kirjed
kuva
Bibliokirje
Lühikirje
reasta
autor kasvavalt
autor kahanevalt
ilmumisaasta kasvavalt
ilmumisaasta kahanevalt
pealkiri kasvavalt
pealkiri kahanevalt
1
artikkel ajakirjas
An alternative approach to distinguish movements of Parkinson disease patients
Nõmm, Sven
;
Toomela, Aaro
;
Vaske, Martti
;
Uvarov, Dan
;
Taba, Pille
IFAC-PapersOnLine
2016
/
p. 272-276 : ill
https://doi.org/10.1016/j.ifacol.2016.10.546
artikkel ajakirjas
2
artikkel ajakirjas
Coordination of zinc ions to the key proteins of neurodegenerative diseases: A[beeta], APP, [alfa]-synuclein and PrP
Tõugu, Vello
;
Palumaa, Peep
Coordination chemistry reviews
2012
/
p. 2219-2224 : ill
artikkel ajakirjas
Kirjeid leitud 2, kuvan
1 - 2
pealkiri
49
1.
An alternative approach to distinguish movements of Parkinson disease patients
2.
Sentence writing test for Parkinson disease modeling: comparing predictive ability of classifiers
3.
CNN based analysis of the Luria’s alternating series test for Parkinson’s disease diagnostics
4.
Detailed analysis of the Luria's alternating series tests for Parkinson's disease diagnostics
5.
Determining necessary length of the alternating series test for Parkinson's disease modelling
6.
Gait analysis based approach for Parkinson's disease modeling with decision tree classifiers
7.
Generative adversarial networks as a data augmentation tool for CNN-based Parkinson's disease diagnostics
8.
Interpretable quantitative description of the digital clock drawing test for Parkinson's disease modelling
9.
Machine learning based analysis of the upper limb freezing during handwriting in Parkinson's disease patients
10.
Parkinson's disease diagnostics based on the analysis of digital sentence writing test
11.
Tremor-related feature engineering for machine learning based Parkinson’s disease diagnostics
12.
Deep CNN based classification of the Archimedes spiral drawing tests to support diagnostics of the Parkinson’s disease
13.
Mathematical and physical modelling of the dynamic electrical impedance both of a healthy neuron and one affected by Parkinson’s disease
14.
Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease
15.
Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease
16.
Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy
17.
The metabolic pattern could be used for early detection of stable ischemic heart disease and hypertensive heart disease
18.
Alternative splicing in health and disease = Alternatiivne splaising haiges ja terves koes
19.
Antibody response to oral biofilm is a biomarker for acute coronary syndrome in periodontal disease
20.
Aortic and arterial pulse wave velocity in patients with coronary heart disease of different severity
21.
Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery disease
22.
Association between renal function and troponin T over time in stable chronic kidney disease patients
23.
Association of Longitudinal High-Sensitivity Troponin T with mortality in patients with chronic kidney disease
24.
Cognitive disorders in patients with chronic kidney disease : specificities of clinical assessment
25.
Copper(I)-binding properties of de-coppering drugs for treatment of Wilson disease
26.
Development of DH in a disease-resistant T.timopheevi-derived wheat population
27.
Development of diagnostic algorithm for von Willebrand disease within WFH the Twinning Tallinn-Helsinki program
28.
Erectile dysfunction in hypertension and cardiovascular disease : a guide for clinicians
29.
European Society of Cardiology: cardiovascular disease statistics 2019
30.
Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop
31.
Glutenfree bread for persons with celiac disease
32.
Glutenfree bread for persons with coeliac disease
33.
Intima-media thickness of the common carotid artery of patients with chronic kidney disease
34.
Migration from HL7 CDA to FHIR in infectious disease system of Estonia
35.
Neurotrophic factors in development and disease
36.
Physical overload disease detection and prevention of industrial and office workers [Electronic resource]
37.
Preventing the onset of disease [Electronic resource]
38.
Retroelements in human disease
39.
Sensitivity of platelets to PAF in patients with coronary artery disease
40.
Sensitivity of platelets to prostaglandins in patients with coronary artery disease
41.
Smart healthcare : disease prediction using the cuckoo-enabled deep classifier in IoT framework
42.
Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease
43.
The metabolic profile of ishemic heart disease by serum 1H NMR
44.
The metabolic profile of stable ischemic heart disease by serum 1H NMR
45.
The missing link in the amyloid cascade of Alzheimer's disease - metal ions
46.
Transcription factors FOXO3 and TCF4 in Huntington’s disease = Transkriptisoonifaktorid FOXO3 ja TCF4 Huntingtoni tõves
47.
Wearable m-assessment system for neurological disease patients
48.
Vibration disease risk estimation in Estonian occupational activities
49.
2022: The year in cardiovascular disease – the year of upfront lipid lowering combination therapy
võtmesõna
37
1.
Parkinson disease
2.
Parkinson’s disease
3.
Parkinson’s disease machine learning
4.
Parkinson's disease
5.
Parkinson’s diseas
6.
Alzheimer’s disease
7.
Alzheimer's disease
8.
anti-GBM disease
9.
cardiovascular disease
10.
celiac disease
11.
cerebrovascular disease
12.
chronic kidney disease
13.
coronary artery disease
14.
coronary artery disease (CAD)
15.
coronary heart disease
16.
disease
17.
disease model
18.
end stage renal disease
19.
end-stage kidney disease
20.
garment workers and patients with occupational disease
21.
Huntington’s disease
22.
infectious disease
23.
in-transit disease
24.
late blight disease
25.
loco-regionally metastatic disease
26.
lyme disease
27.
mechanisms of disease
28.
molecular bases of disease
29.
NAFLD (non-alcoholic fatty liver disease)
30.
neurodegenerative disease
31.
non-alcoholic fatty liver disease
32.
oat striate and red disease
33.
physical overload disease
34.
renal disease
35.
stable coronary heart disease
36.
subclinical cardiovascular disease
37.
von Willebrand disease
allikas
11
1.
New Trends in Alzheimer and Parkinson Disorders : ADPD 2009
2.
Cell death & disease
3.
Colorectal disease
4.
Disease Models & Mechanisms
5.
Erectile dysfunction in hypertension and cardiovascular disease : a guide for clinicians
6.
International Symposium on Trace Elements in Health and Disease, Espoo, Finland, 5-8 June 1990 : abstracts
7.
Journal of Alzheimer's disease
8.
Journal of Alzheimer's Disease Reports
9.
Microbial ecology in health and disease
10.
Plant disease
11.
The Third International Meeting : Hirschsprung Disease and Related Neurochristopathies, Evian, February 5-8, 1998